1. Incidence and prognosis of COVID‐19 in patients with psoriasis on apremilast: a multicentre retrospective cohort study. (28th October 2021) Authors: Lytvyn, Y.; Georgakopoulos, J.R.; Mufti, A.; Devani, A.R.; Gooderham, M.J.; Jain, V.; Lansang, P.; Vender, R.; Prajapati, V.H.; Yeung, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 2(2022) Page Start: e94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I randomized study of KHK4083, an anti‐OX40 monoclonal antibody, in patients with mild to moderate plaque psoriasis. (14th June 2017) Authors: Papp, K.A.; Gooderham, M.J.; Girard, G.; Raman, M.; Strout, V. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 8(2017) Page Start: 1324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Psoriasis patients' preference for an aerosol foam topical formulation. (3rd May 2018) Authors: Vender, R.; Gooderham, M.J.; Guenther, L.C.; Kyritsis, D.; Rao, J.; Kowalczyk, A.; Ashkenas, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 11(2018) Page Start: e400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study. (25th August 2021) Authors: Gulliver, W.; Alavi, A.; Wiseman, M.C.; Gooderham, M.J.; Rao, J.; Alam, M.S.; Papp, K.A.; Desjardins, O.; Jean, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 12(2021) Page Start: 2431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting. (1st April 2022) Authors: Papp, K.A.; Gooderham, M.J.; Albrecht, L.E.; Raymond, M.‐A.; Lynde, C.W. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real‐world setting. (20th January 2022) Authors: Papp, K.A.; Gooderham, M.J.; Albrecht, L.E.; Raymond, M.‐A.; Lynde, C.W. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗